These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 34080991)

  • 21. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
    Rid A; Lipsitch M; Miller FG
    JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementing digital passports for SARS-CoV-2 immunization in Canada.
    Wilson K; Flood CM
    CMAJ; 2021 Apr; 193(14):E486-E488. PubMed ID: 33658246
    [No Abstract]   [Full Text] [Related]  

  • 23. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
    Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
    Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
    Schmidt H; Gostin LO; Williams MA
    JAMA; 2020 Nov; 324(20):2023-2024. PubMed ID: 33052391
    [No Abstract]   [Full Text] [Related]  

  • 25. With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines.
    Su Z; McDonnell D; Cheshmehzangi A; Li X; Maestro D; Šegalo S; Ahmad J; Hao X
    JMIR Public Health Surveill; 2021 Aug; 7(8):e26111. PubMed ID: 33560997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covid-19 vaccine passports: access, equity, and ethics.
    Osama T; Razai MS; Majeed A
    BMJ; 2021 Apr; 373():n861. PubMed ID: 33795260
    [No Abstract]   [Full Text] [Related]  

  • 28. Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.
    Aripov T; Wikler D; Asadov D; Tulekov Z; Murzabekova T; Munir KM
    BMC Med Ethics; 2022 Mar; 23(1):21. PubMed ID: 35264173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Considerations on the clinical development of COVID-19 vaccine from trial design perspectives.
    Jiang Z; Wang X; Xia J
    Hum Vaccin Immunother; 2021 Mar; 17(3):656-660. PubMed ID: 32991223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethical reflections on Covid-19 vaccines.
    Raus K; Mortier E; Eeckloo K
    Acta Clin Belg; 2022 Jun; 77(3):600-605. PubMed ID: 34008482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status of vaccine development for COVID-19.
    Mendes A
    Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
    [No Abstract]   [Full Text] [Related]  

  • 33. Voluntary COVID-19 vaccination of children: a social responsibility.
    Brusa M; Barilan YM
    J Med Ethics; 2021 Aug; 47(8):543-546. PubMed ID: 34117126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.
    Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X
    JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mandatory COVID-19 vaccination and human rights.
    King J; Ferraz OLM; Jones A
    Lancet; 2022 Jan; 399(10321):220-222. PubMed ID: 34953527
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 vaccination in India: An ethical perspective.
    Sharma P; Pardeshi G
    Diabetes Metab Syndr; 2021; 15(6):102314. PubMed ID: 34678577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
    Schulze-Koops H; Specker C; Skapenko A
    RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [COVID-19: Would compulsory vaccination be legally possible?].
    Frielitz FS; Wagner IV; Schewe DM; Bothe K
    Dtsch Med Wochenschr; 2021 Feb; 146(3):206-208. PubMed ID: 33440433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited.
    Zimmerman RK; South-Paul JE; Poland GA
    J Infect Dis; 2020 Nov; 222(11):1776-1779. PubMed ID: 32894861
    [No Abstract]   [Full Text] [Related]  

  • 40. Implementing the Epidemic Diseases Act to combat Covid-19 in India: An ethical analysis.
    Rakesh PS
    Indian J Med Ethics; 2021; VI(1):1-10. PubMed ID: 34080990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.